FANCD2 and cervical carcinoma: To assess the association of our cervical carcinoma-specific fragile-site dataset with HPV integration sites, we calculated the frequency with which an integration breakpoint occurred within 50 Kb9 of the C33-A and HeLa FANCD2-enriched regions (Supplementary Data Table 10).